Motilal Oswal recommended Neutral rating on DLF with a target price of Rs 385 in its research report dated September 02, 2022.
Posts tagged MC
Neutral DLF; target of Rs 385: Motilal Oswal (05-09-2022)
Balaji Amines: Value unlocking opportunity on the cards (05-09-2022)
In the domestic market, growth visibility for the subsidiary comes from capacity expansion plans of the company’s key clients – Indofil, UPL and Aarti industries
Balaji Amines: Spot the value unlocking chemistry (05-09-2022)
In the domestic market, growth visibility for the subsidiary comes from capacity expansion plans of the company’s key clients – Indofil, UPL and Aarti industries
Buy Abbott India; target of Rs 22,780: Sharekhan (05-09-2022)
Sharekhan is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 22,780 in its research report dated September 02, 2022.
Buy Balkrishna Industries; target of Rs 2293: Hem Securities (05-09-2022)
Hem Securities is bullish on Balkrishna Industries has recommended buy rating on the stock with a target price of Rs 2293 in its research report dated September 03, 2022.
Buy Balkrishna Industries; target of Rs 2293: Hem Securities (05-09-2022)
Hem Securities is bullish on Balkrishna Industries has recommended buy rating on the stock with a target price of Rs 2293 in its research report dated September 03, 2022.
Accumulate Ambuja Cement; target of Rs 448: Hem Securities (05-09-2022)
Hem Securities recommended accumulate rating on Ambuja Cement with a target price of Rs 448 in its research report dated September 02, 2022.
Concor – A robust play for the long term (05-09-2022)
Long-term prospects of Concor appear fairly bright with the impending privatisation of the business and the completion of dedicated freight corridors
Concor – A solid long-term buy (05-09-2022)
Long-term prospects of Concor appear fairly bright with the impending privatisation of the business and the completion of dedicated freight corridors
Buy Krsnaa Diagnostics; target of Rs 868: Khambatta Securities (02-09-2022)
Khambatta Securities is bullish on Krsnaa Diagnostics has recommended buy rating on the stock with a target price of Rs 868 in its research report dated September 02, 2022.